Controlsb | gp43 (45–59)c | gp43 (94–108 c | gp43 (106–120)c | gp43 (283–298)c | gp43 (180–194)c | gp43 1 µg | PHA |
---|
0.1 | 1.0 | 10.0 | 0.1 | 1.0 | 10.0 | 0.1 | 1.0 | 10.0 | 0.1 | 1.0 | 10.0 | 0.1 | 1.0 | 10.0 |
---|
c1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 234.1 |
c2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 439.2 |
c3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 232.1 |
c4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 216.4 |
c5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 353.2 |
c6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 545.3 |
- aOnly positive stimulation index values (SI ≥ 2) are shown. Dash (-) corresponds to SI < 2.
- bc = healthy control individual.
- cPBMC (105 cells/well) were stimulated with peptides at 0.1, 1.0, and 10.0 µM as described.